Live Breaking News & Updates on Pharmacia Corporation|Page 6
Stay updated with breaking news from Pharmacia corporation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Antares Pharma Appoints Joseph Renda as Senior Vice President of Commercial streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Published: May 06, 2021 EWING, N.J., May 06, 2021 (GLOBE NEWSWIRE) Antares Pharma, Inc.. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced the appointment of Joseph V. Renda as Senior Vice President of Commercial. Mr. Renda succeeds Patrick Shea who resigned to pursue other interests. Mr. Renda has had a successful career in leading commercial sales, marketing, and operations at large and mid-sized pharmaceutical companies. Prior to joining Antares, Mr. Renda was Vice President, U.S. Sales Autoimmune and Rare Disease at Mallinckrodt Pharmaceuticals where he led a 200-person organization responsible for over $1B in annual sales and managed 5 unique therapeutic areas and institutional account teams. From 2012 to 2018, he held various positions of increasing responsibility at Novo Nordisk including Marketing Brand Director, Women’s Health Care and leading the commercial operations and effectiveness function responsible for a 150- ....
Antares Pharma Appoints Joseph Renda as Senior Vice President of Commercial May 06, 2021 07:15 ET | Source: Antares Pharma, Inc. Antares Pharma, Inc. Ewing, New Jersey, UNITED STATES EWING, N.J., May 06, 2021 (GLOBE NEWSWIRE) Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”), a specialty pharmaceutical company, today announced the appointment of Joseph V. Renda as Senior Vice President of Commercial. Mr. Renda succeeds Patrick Shea who resigned to pursue other interests. Mr. Renda has had a successful career in leading commercial sales, marketing, and operations at large and mid-sized pharmaceutical companies. Prior to joining Antares, Mr. Renda was Vice President, U.S. Sales Autoimmune and Rare Disease at Mallinckrodt Pharmaceuticals where he led a 200-person organization responsible for over $1B in annual sales and managed 5 unique therapeutic areas and institutional account teams. From 2012 to ....
Press release content from Business Wire. The AP news staff was not involved in its creation. Athersys Announces CEO Transition CLEVELAND, Ohio (BUSINESS WIRE) Feb 16, 2021 Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem ® cell therapy, today announced that Dr. Gil Van Bokkelen has stepped down as Chairman and Chief Executive Officer, effective immediately. The Athersys Board has appointed William (B.J.) Lehmann, the Company’s President and Chief Operating Officer, as Interim Chief Executive Officer. Dr. Ismail Kola, Lead Director of the Athersys Board, has been appointed Chairman of the Board. The Company’s Board is commencing a comprehensive search process to identify a permanent CEO. The Board intends to identify and select a CEO who can guide Athersys in the commercial stage. ....
Risk of being convicted the shell company would take the hit. think of it as the great-great grandson of the parent company. birthday? march 27th, 2007. just in time to plead guilty in a kickback case against the company pfizer had acquired a few years earlier. with that conviction, pharmacia and upjohn company incorporated which had never sold so much as a single pill, was excluded from medicare. two years later when pfizer was in trouble with bextra, pharmacia and upjohn company incorporated, the shell company, stepped up again and pleaded guilty. it was like having an imaginary friend. an imaginary bad guy to take the rap. and pfizer, too big to nail, is still doing business with the federal government. it is true that if a company ....